Early circulating tumor cell dynamics were associated with overall survival in patients with metastatic breast…
View More CTC dynamics may predict treatment response/prognosis in metastatic breast cancer patients
Home »
New drug for metastatic colorectal cancer enters phase 3 trial
A new therapy for metastatic colorectal cancer that has been granted fast-track designation by the…
View More New drug for metastatic colorectal cancer enters phase 3 trial
FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer
April 4, 2019 — Pfizer (NYSE:PFE) today announced that the U.S. Food and Drug Administration…
View More FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer